Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-2009 | 04-2009 | 01-2009 | 10-2008 | 07-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,003 | -2,242 | -855 | -292 | -131 |
| Depreciation Amortization | 8 | 4 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1 | 881 | 547 | 160 | 41 |
| Other Working Capital | -73 | 602 | 483 | -464 | -138 |
| Other Operating Activity | 51 | -133 | -223 | -59 | 21 |
| Operating Cash Flow | $-1,018 | $-888 | $-48 | $-655 | $-207 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,017 | -1,017 | -1,005 | N/A | N/A |
| PPE Investments | -44 | -69 | -38 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -57 | N/A | -9 | -14 |
| Other Investing Activity | 0 | -64 | 0 | -9 | -14 |
| Investing Cash Flow | $973 | $-1,150 | $-1,043 | $-9 | $-14 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3 | 57 | 7 | 7 | 7 |
| Common Stock Repurchased | -156 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-153 | $57 | $7 | $7 | $7 |
| Beginning Cash Position | 1,728 | 3,709 | 3,709 | 3,709 | 3,709 |
| End Cash Position | 1,530 | 1,728 | 2,625 | 3,052 | 3,495 |
| Net Cash Flow | $-198 | $-1,981 | $-1,084 | $-657 | $-214 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,018 | -888 | -48 | -655 | -207 |
| Capital Expenditure | -44 | -69 | -38 | N/A | N/A |
| Free Cash Flow | -1,062 | -957 | -86 | -655 | -207 |